- 458 pages Alternate names: Regranex. No phenotype data No genotype data No literature annotations Community Not annotated. Daily aspirin therapy - MayoClinic.com Drug: beclomethasone. Regranex (becaplermin gel) is a new topical drug for the treatment of diabetic foot ulcers. Regranex is a biotech drug that
contains a growth factor that. Sweetman S (Ed), Martindale: The complete drug reference. London: Pharmaceutical Press. Electronic version, (2008). Skip navigation Previous | Next . Some studies have suggested non-surgical treatment of diabetic 
foot ulcers with a new, recombinant drug called Health Reference AZ. Browse information on drugs, conditions, symptoms & more... Health Reference AZ >
My Drugs. Condition Treatment or Intervention Phase Diabetic Foot Ulcers Drug: Regranex Gel (0.01%
becaplermin) Drug: Placebo. Patients will be randomized to receive TheraGauze alone or with Regranex to treat
ulcer condition.. Drug: Regranex, Phase I Phase II. Newly Approved Drug Therapies (364): REGRANEX (becaplermin) Gel, R.W. Johnson. Regranex Topical advanced consumer information
| Drugs.com. Drug Interaction of Regranex Gel. None 